The findings have the potential to pave the way for new disease-modifying treatments for patients with Parkinson’s disease. A study published in Nature Communications by Beth Israel Deaconess Medical Center (BIDMC) investigators provides new insights into cellular mechanisms in Parkinson's disease

This study reveals that inhibiting a specific enzyme, USP30, in a mouse model can protect dopamine-producing neurons. This finding halts the disease’s progression and opens the door to new therapeutic possibilities for the 10 million people affected by Parkinson’s worldwide.

DOI: 10.1038/s41467-023-42876-1

https://www.nature.com/articles/s41467-023-42876-1

  • @CmdrShepardEnglish
    1•7 months ago

    I saw it posted all over Lemmy within days of the original claim. Apart from notifying you personally to any changes, how would you really correct this?